These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7678977)

  • 1. Epidermal growth factor and transforming growth factor alpha concentrations in BPH and cancer of the prostate: their relationships with tissue androgen levels.
    Yang Y; Chisholm GD; Habib FK
    Br J Cancer; 1993 Jan; 67(1):152-5. PubMed ID: 7678977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth factors in expressed prostatic fluid from men with prostate cancer, BPH, and clinically normal prostates.
    Gann PH; Klein KG; Chatterton RT; Ellman AE; Grayhack JT; Nadler RB; Lee C
    Prostate; 1999 Sep; 40(4):248-55. PubMed ID: 10420153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between oestradiol-17 beta, testosterone, dihydrotestosterone and 5 alpha-androstane-3 alpha, 27 beta-diol in human benign hypertrophy and carcinoma of the prostate.
    Ghanadian R; Puah CM
    J Endocrinol; 1981 Feb; 88(2):255-62. PubMed ID: 6162906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgens regulate proliferation of human prostate cancer cells in culture by increasing transforming growth factor-alpha (TGF-alpha) and epidermal growth factor (EGF)/TGF-alpha receptor.
    Liu XH; Wiley HS; Meikle AW
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1472-8. PubMed ID: 8263129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of transforming growth factor-alpha, epidermal growth factor and the epidermal growth factor receptor in adenocarcinoma of the prostate and benign prostatic hyperplasia.
    Myers RB; Kudlow JE; Grizzle WE
    Mod Pathol; 1993 Nov; 6(6):733-7. PubMed ID: 7508115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of MENT on primary cell cultures from benign prostatic hyperplasia and prostate carcinoma.
    Mendoza P; Sánchez C; Contreras HR; Vergara J; Acevedo C; Cabezas J; Huidobro C; Noé G; Castellón EA
    Int J Androl; 2009 Dec; 32(6):607-15. PubMed ID: 18637152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex steroids and epidermal growth factor in benign prostatic hyperplasia (BPH).
    Sciarra F
    Ann N Y Acad Sci; 1995 Jun; 761():66-78. PubMed ID: 7542859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential gene expression of transforming growth factors alpha and beta, epidermal growth factor, keratinocyte growth factor, and their receptors in fetal and adult human prostatic tissues and cancer cell lines.
    Dahiya R; Lee C; Haughney PC; Chui R; Ho R; Deng G
    Urology; 1996 Dec; 48(6):963-70. PubMed ID: 8973690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens.
    Monti S; Di Silverio F; Iraci R; Martini C; Lanzara S; Falasca P; Poggi M; Stigliano A; Sciarra F; Toscano V
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1700-6. PubMed ID: 11297606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia.
    Di Silverio F; Monti S; Sciarra A; Varasano PA; Martini C; Lanzara S; D'Eramo G; Di Nicola S; Toscano V
    Prostate; 1998 Oct; 37(2):77-83. PubMed ID: 9759701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalent decrease of the EGF content in the periurethral zone of BPH tissue induced by treatment with finasteride or flutamide.
    Monti S; Sciarra F; Adamo MV; Toscano V; Trotta MC; Martini C; Lanzara S; Silverio FD
    J Androl; 1997; 18(5):488-94. PubMed ID: 9349746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines.
    Ching KZ; Ramsey E; Pettigrew N; D'Cunha R; Jason M; Dodd JG
    Mol Cell Biochem; 1993 Sep; 126(2):151-8. PubMed ID: 7508078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer.
    van der Sluis TM; Vis AN; van Moorselaar RJ; Bui HN; Blankenstein MA; Meuleman EJ; Heijboer AC
    BJU Int; 2012 Jan; 109(2):176-82. PubMed ID: 21992222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of steroids on oxytocin secretion by the human prostate in vitro.
    Assinder SJ; Nicholson HD
    Int J Androl; 2004 Feb; 27(1):12-8. PubMed ID: 14718041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen concentration in blacks with benign and malignant prostatic disease.
    Osegbe DN; Ogunlewe JO
    J Urol; 1988 Jul; 140(1):160-4. PubMed ID: 2454327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor.
    Brass AL; Barnard J; Patai BL; Salvi D; Rukstalis DB
    Cancer Res; 1995 Jul; 55(14):3197-203. PubMed ID: 7606741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor, epidermal growth factor receptor, and transforming growth factor-alpha in human hyperplastic prostate tissue: expression and cellular localization.
    De Bellis A; Ghiandi P; Comerci A; Fiorelli G; Grappone C; Milani S; Salerno R; Marra F; Serio M
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4148-54. PubMed ID: 8923874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of mRNA and protein expression for epidermal growth factor receptor and ligands relative to the proliferative index in human prostate tissue.
    Glynne-Jones E; Goddard L; Harper ME
    Hum Pathol; 1996 Jul; 27(7):688-94. PubMed ID: 8698313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone and dihydrotestosterone levels in the transition zone correlate with prostate volume.
    Pejčić T; Tosti T; Tešić Ž; Milković B; Dragičević D; Kozomara M; Čekerevac M; Džamić Z
    Prostate; 2017 Jul; 77(10):1082-1092. PubMed ID: 28594074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue and serum levels of principal androgens in benign prostatic hyperplasia and prostate cancer.
    Heracek J; Hampl R; Hill M; Starka L; Sachova J; Kuncova J; Eis V; Urban M; Mandys V
    Steroids; 2007 Apr; 72(4):375-80. PubMed ID: 17368496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.